期刊文献+

单宁酸对高糖下大鼠肾小球系膜细胞增殖及细胞周期的影响 被引量:1

Effects of gallotannin on proliferation and cell cycle of rat glomerular mesangial cells under condition of high glucose
下载PDF
导出
摘要 目的:探讨单宁酸(GLTN)对高糖诱导的大鼠肾小球系膜细胞(GMC)增殖的抑制作用及对细胞周期的影响,阐明GLTN对糖尿病肾病(DN)发生发展的延缓作用。方法:实验细胞分成正常糖对照组(D-葡萄糖5.5mmol·L^(-1),NC组)、高糖组(D-葡萄糖30mmol·L^(-1),HC组)、高糖+5mmol·L^(-1) 3-氨甲苯甲酰胺(3-AB,AB组)、高糖+20μmol·L^(-1) GLTN(G20组)和高糖+40μmol·L^(-1) GLTN(G40组)。MTT法观察不同时间点(4、8、24、48和72h)各组GMC的增殖情况,流式细胞术观察细胞周期,Western blotting法检测转化生长因子β1(TGF-β1)和结缔组织生长因子(CTGF)的蛋白表达情况。结果:与NC组比较,高糖组GMC增殖水平升高(P<0.01),于48h时达高峰;S期细胞百分比明显升高(P<0.01)。与HC组比较,各给药组GMC增殖水平均明显下降(P<0.01),S期细胞百分比降低(P<0.01)。与NC组比较,各给药组S期细胞百分比明显升高(P<0.05或P<0.01),TGF-β1和CTGF蛋白表达水平升高(P<0.05或P<0.01),但与HC组比较明显下降(P<0.01)。结论:单宁酸可通过阻滞细胞周期,下调TGF-β1和CTGF的表达,抑制高糖诱导的大鼠GMC的增殖,从而对DN的发生发展起到一定的延缓作用。 Objective: To explore the inhibitory effect of gallotannin (GLTN) on the proliferation of rat glomerular mesangial cells (GMC)induced by high sugar stimulation and the influence in the cell cycle of the rats, and to clarify the prevention effect of GLTN in the occurrence and development of diabetic nephropathy (DN). Methods:The experimental cells were divided into normal control group (D-glucose 5.5 mmol·L-1 ,NC group), high glucose group (D-glucose 30 mmol· L-1 ,HC group),high glucose + 5 mmol· L-1 3 - AB group (AB group),high glucose + 20 μmol·L-1 GLTN group (G20 group),high glucose + 40 μmol· L-1 GLTN group (G40 group).The proliferation of GMC in different groups at different time points (4,8,24,48 and 72 h)was&amp;nbsp;observed by MTT assay.The changes of cell cycle of GCM under different culture conditions were examined by flow cytometry,and the expression levels of TGF-β1 and CTGF were detected by Western blotting method. Results:Compared with NC group,the proliferation levels of GMC in HC group were increased (P 〈0.01),and reached the peak at 48 h ;the percentage of S phase cells was increased (P 〈0.01).Compared with HC group,the proliferation levels of GMC in 3-AB group and GLTN group were significantly decreased (P 〈 0.01 ),and the percentages of S phase cells were decreased (P 〈0.01).Compared with NC group,the protein expression levels of TGF-β1 and CTGF in each drug group were increased (P 〈 0.05 or P 〈 0.01),but they were significantly lower than those in HC group (P 〈 0.01).Conclusion:GLTN can inhibit the proliferation of GMC under high sugar stimulation through arresting the cell cycle and down-regulating the expressions of TGF-β1 and CTGF and delay the occurrence and development of DN.
出处 《吉林大学学报(医学版)》 CAS CSCD 北大核心 2016年第5期920-924,共5页 Journal of Jilin University:Medicine Edition
基金 吉林省教育厅科研计划项目资助课题(吉教科合字[2014]第196号) 吉林省卫生厅科研基金资助课题(2014Z082) 北华大学创新团队科研项目资助课题(20141225) 北华大学博士启动基金项目资助课题(20130701)
关键词 单宁酸 糖尿病肾病 细胞增殖 细胞周期 转化生长因子Β1 结缔组织生长因子 gallotannin diabetic nephropathy cell proliferation cell cycle connective tissue growth factor
  • 相关文献

参考文献18

  • 1Cherney DZ.Advances in the treatment of diabetic nephropathy[J].Nephrol News Issues,2013,7(5):18,33.
  • 2Appel G.Detecting and controlling diabetic nephropathy:what do we know[J].Cleve Clin J Med,2013,80(4):209-217.
  • 3Singh AK,Singh J.Evaluation of anti-diabetic potential of leaves and stem of Flacourtia jangomas in streptozotocininduced diabetic rats[J].Indian J Pharmacol,2010,42(5):301-305.
  • 4Chandak PG,Gaikwad AB,Tikoo K.Gallotannin ameliorates the development of streptozotocin-induced diabetic nephropathy by preventing the activation of PARP[J].Phytother Res,2009,23(1):72-77.
  • 5Brownlee M.The pathobiology of diabetic complications:a unifying mechanism[J].Diabetes,2005,54(6):1615-1625.
  • 6Smith MA,Hampton OA,Reynolds CP,et al.Initial testing(stage 1)of the PARP inhibitor BMN 673by the pediatric preclinical testing program:PALB2 mutation predicts exceptional in vivo response to BMN 673[J].Pediatr Blood Cancer,2015,62(1):91-98.
  • 7Jang NY,Kim DH,Cho BJ,et al.Radiosensitization with combined use of olaparib and PI-103in triple-negative breast cancer[J].BMC Cancer,2015,15:89.
  • 8Yao H,Ji M,Zhu Z,et al.Discovery of 1-substituted benzylquinazoline-2,4(1H,3H)-dione derivatives as novel poly(ADP-ribose)polymerase-1 inhibitors[J].Bioorg Med Chem,2015,23(4):681-693.
  • 9Faraoni I,Compagnone M,Lavorgna S,et al.BRCA1,PARP1 andγH2AX in acute myeloid leukemia:Role as biomarkers of response to the PARP inhibitor olaparib[J].Biochim Biophys Acta,2015,1852(3):462-472.
  • 10Lupachyk S,Shevalye H,Maksimchyk Y,et al.PARP inhibition alleviates diabetes-induced systemic oxidative stress and neural tissue 4-hydroxynonenal adduct accumulation:Correlation with peripheral nerve function[J].Free Radic Biol Med,2011,50(10):1400-1409.

同被引文献14

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部